PT2411410E - Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície - Google Patents

Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície Download PDF

Info

Publication number
PT2411410E
PT2411410E PT107450314T PT10745031T PT2411410E PT 2411410 E PT2411410 E PT 2411410E PT 107450314 T PT107450314 T PT 107450314T PT 10745031 T PT10745031 T PT 10745031T PT 2411410 E PT2411410 E PT 2411410E
Authority
PT
Portugal
Prior art keywords
spore
screening
compositions
methods
surface interactions
Prior art date
Application number
PT107450314T
Other languages
English (en)
Portuguese (pt)
Inventor
Sarah L Edmonds
David R Macinga
James Edmund Bingham
Original Assignee
Gojo Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gojo Ind Inc filed Critical Gojo Ind Inc
Publication of PT2411410E publication Critical patent/PT2411410E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
PT107450314T 2009-03-27 2010-03-26 Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície PT2411410E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16415409P 2009-03-27 2009-03-27

Publications (1)

Publication Number Publication Date
PT2411410E true PT2411410E (pt) 2015-10-09

Family

ID=43032739

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107450314T PT2411410E (pt) 2009-03-27 2010-03-26 Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície

Country Status (13)

Country Link
US (1) US20100291100A1 (enExample)
EP (1) EP2411410B1 (enExample)
JP (1) JP5911421B2 (enExample)
KR (1) KR20110140128A (enExample)
CN (1) CN102388064A (enExample)
AU (1) AU2010241947B2 (enExample)
BR (1) BRPI1014121A2 (enExample)
CA (1) CA2756760A1 (enExample)
DK (1) DK2411410T3 (enExample)
ES (1) ES2544435T3 (enExample)
PT (1) PT2411410E (enExample)
TW (1) TW201039841A (enExample)
WO (1) WO2010126670A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133251B2 (en) * 2008-02-22 2015-09-15 The Curators Of The University Of Missouri Bacillus based delivery system and methods of use
US20130243794A1 (en) * 2010-12-03 2013-09-19 Beth Israel Deaconess Medical Center, Inc. Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
CA2834402A1 (en) * 2010-12-29 2012-07-05 Cangene Corporation Clostridium difficile antigens
GB2491117A (en) * 2011-05-20 2012-11-28 Royal Holloway & Bedford New College Coat proteins from Clostridium and Bacillus species
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2014193237A2 (en) * 2013-05-30 2014-12-04 Academisch Ziekenhuis Leiden H.O.D.N. Lumc C diff protease
US20160250283A1 (en) * 2013-10-23 2016-09-01 The Rockefeller University Compositions and methods for prophylaxis and therapy of clostridium difficile infection
GB2525177A (en) * 2014-04-14 2015-10-21 New Royal Holloway & Bedford Vaccine
IL315468A (en) 2014-09-17 2024-11-01 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
CN108884434B (zh) * 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
WO2018129249A1 (en) * 2017-01-05 2018-07-12 The University Of Chicago Inhibition of enteric infection through the modulation of microbiota
WO2019060574A1 (en) 2017-09-20 2019-03-28 Spogen Biotech Inc. FUSION PROTEINS, RECOMBINANT BACTERIA AND EXIN FRAGMENTS FOR PLANT HEALTH
CN109706101B (zh) * 2019-02-01 2022-10-11 东华大学 一种嗜冷芽孢八叠球菌及其应用
JP2022535131A (ja) 2019-06-05 2022-08-04 リブ・プロセス・インコーポレイテッド クロストリジウム・ディフィシル菌に対するアプタマー
CN110879209A (zh) * 2019-12-09 2020-03-13 济南大学 一种γ-氨基丁酸的快速检测方法
JP2023522072A (ja) * 2020-04-17 2023-05-26 リブ・プロセス・インコーポレイテッド クロストリディオイデス・ディフィシル菌のコロニー形成を低減または予防する方法
CN111909945B (zh) * 2020-08-31 2022-01-25 南京工业大学 一种提高梭菌中蛋白表达效率的方法
US11898146B2 (en) * 2020-12-03 2024-02-13 Liv Process, Inc. Aptamers against Clostridium difficile, compositions comprising aptamers against Clostridium difficile and methods of using the same
JPWO2022209994A1 (enExample) * 2021-03-30 2022-10-06
CN113247946B (zh) * 2021-04-22 2022-07-05 哈尔滨工业大学 一种自组装纳米生物催化剂及其制备方法和在丁醇生产中的应用
CN113308431B (zh) * 2021-06-15 2022-09-16 广西大学 一种番茄灰霉病菌分生孢子的移植与分散方法
CN113278578B (zh) * 2021-06-15 2022-09-16 广西大学 一种稻瘟病菌分生孢子的移植方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28778E (en) * 1969-12-23 1976-04-20 West Laboratories, Inc. Phenolic synthetic detergent-disinfectant
NL7018669A (enExample) 1969-12-23 1971-06-25
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4632772A (en) 1982-02-22 1986-12-30 Dexide, Inc. Mild antimicrobial detergent composition
US5051448A (en) 1984-07-24 1991-09-24 The Mclean Hospital Corporation GABA esters and GABA analog esters
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5288486A (en) 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US4981785A (en) 1988-06-06 1991-01-01 Ventrex Laboratories, Inc. Apparatus and method for performing immunoassays
US5169862A (en) 1989-07-07 1992-12-08 Peptide Technologies Corporation Analogs of viscosin and their uses
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5114978A (en) * 1990-10-15 1992-05-19 Rhone-Poulenc Surfactants And Specialties, L.P. Anhydrous blends of p-chloro-m-xylenol in surfactant mixtures
US5376313A (en) 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5541061A (en) * 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
DE69314148T2 (de) 1992-12-17 1998-01-15 Valeo Systemes Essuyage Stromversorgungsverfahren und -vorrichtung für einen elektrischen Motor zum Antrieb eines Scheibenwischers eines Kraftfahrzeugs
US5576220A (en) 1993-02-19 1996-11-19 Arris Pharmaceutical Corporation Thin film HPMP matrix systems and methods for constructing and displaying ligands
US5559103A (en) 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
US5539085A (en) 1993-08-20 1996-07-23 Onyx Pharmaceuticals, Inc. Bcl-2 and R-ras complex
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5519134A (en) * 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) * 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
US5635462A (en) 1994-07-08 1997-06-03 Gojo Industries, Inc. Antimicrobial cleansing compositions
US5576423A (en) 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
US5585639A (en) * 1995-07-27 1996-12-17 Hewlett-Packard Company Optical scanning apparatus
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
WO1997023782A1 (en) 1995-12-22 1997-07-03 Abbott Laboratories Fluorescence polarization immunoassay diagnostic method
US5885529A (en) 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
US7655252B2 (en) * 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
EP1251735B1 (en) * 2000-02-01 2005-07-27 Tiax, Llc Chemical and biological decontamination system
US6656919B1 (en) * 2002-01-11 2003-12-02 Clarence L. Baugh Method and a product for the rapid decontamination and sterilization of bacterial endospores
US7192601B2 (en) * 2002-01-18 2007-03-20 Walker Edward B Antimicrobial and sporicidal composition
WO2005013898A2 (en) * 2003-07-11 2005-02-17 Vaxin, Inc. Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
PL1656095T3 (pl) * 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
GB0410958D0 (en) * 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
US7658706B2 (en) * 2005-12-05 2010-02-09 Rti Biologics, Inc. Vascular graft sterilization and decellularization
GB0612456D0 (en) * 2006-06-23 2007-03-28 Secr Defence Antibody for anthrax
CN101190946A (zh) * 2006-12-01 2008-06-04 中国人民解放军第二军医大学 重组恶性疟原虫环子孢子表面蛋白及其制法和用途
CA2714720A1 (en) * 2008-02-28 2009-09-03 3M Innovative Properties Company Antibodies to clostridium difficile spores and uses thereof
JO3421B1 (ar) 2011-06-20 2019-10-20 H Lundbeck As طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية

Also Published As

Publication number Publication date
TW201039841A (en) 2010-11-16
ES2544435T3 (es) 2015-08-31
JP5911421B2 (ja) 2016-05-18
DK2411410T3 (en) 2015-09-07
US20100291100A1 (en) 2010-11-18
AU2010241947B2 (en) 2014-01-16
JP2012522010A (ja) 2012-09-20
CN102388064A (zh) 2012-03-21
AU2010241947A1 (en) 2011-11-17
EP2411410B1 (en) 2015-07-08
CA2756760A1 (en) 2010-11-04
BRPI1014121A2 (pt) 2016-11-08
WO2010126670A2 (en) 2010-11-04
WO2010126670A3 (en) 2011-03-31
EP2411410A2 (en) 2012-02-01
KR20110140128A (ko) 2011-12-30
WO2010126670A9 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
PT2411410E (pt) Composições e métodos para screening e utilização de compostos que antagonizam interações esporo-superfície
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
ZA201006944B (en) Compositions and methods for preparing and using same
EP2483362A4 (en) Fluoropropene compounds and compositions and methods using same
EP2483221A4 (en) FERTILIZER COMPOSITIONS AND METHOD THEREFOR
EP2475777A4 (en) COMPOSITIONS AND METHODS FOR COMPLETE TRANSCRIPTOMAL ANALYSIS
IL214303A (en) Preparation for chemical improvement of soil
ZA201203183B (en) Sulfomethylsuccinates, process for making same and compositions containing same
GB0815872D0 (en) Novel method and compositions
EP2416657A4 (en) COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF
IL213990A0 (en) Compositions for decontamination
IL208445A0 (en) Compositions and methods for immunotherapy
GB0903299D0 (en) Composition and methods
PL2385029T3 (pl) Kompozycje i sposób cementowania odwiertów
GB0912468D0 (en) Composition and method
EP2294199A4 (en) COMPOSITIONS AND METHODS FOR ENHANCING PLANTS
GB0911350D0 (en) Particulate composition
EP2294198A4 (en) METHODS AND COMPOSITIONS FOR ENHANCING PLANTS
IL218325A0 (en) Methods and compositions for producing plants
PL2328402T3 (pl) Sposoby i kompozycje do wydłużenia okresu przechowywania owoców
GB0901494D0 (en) Compositions and Methods
EP2520659A4 (en) SCREENING PROCESS
EP2471918A4 (en) SCREENING METHOD
GB0912394D0 (en) Screening methods
IL217764A0 (en) Methods and compositions for treating leukemia